glp-1 what to expect from Semaglutide for Weight Loss What to Expect After First

(2025), sheds critical light on an often-overlooked aspect of GLP-1 receptor agonist (GLP-1RA) therapy: the risk of micronutrient deficiencies and muscle loss

Figure 1 Key events in the clinical course, including the onset of complications and therapeutic interventions, are summarized in Figure 2

Rachele Pojednic, Restores Chief Science Officer, advises clients to think about why they are walking through the door before their first session

Many individuals see noticeable changes in their weight within the first few months of starting treatment with semaglutide, especially when combined with a broader medical weight management plan that incorporates diet and exercise modifications

Certificate of analysis available upon request